Back to Search
Start Over
Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.
- Source :
-
European journal of pharmacology [Eur J Pharmacol] 2006 Jan 13; Vol. 530 (1-2), pp. 107-16. Date of Electronic Publication: 2005 Dec 22. - Publication Year :
- 2006
-
Abstract
- This study sets out to characterise calcitonin gene-related peptide (CGRP) receptors in human and porcine isolated proximal and distal coronary arteries using BIBN4096BS. Human (h)-alphaCGRP induced relaxations that were blocked by BIBN4096BS in all arteries studied. In contrast to the other vessels, the Schild plot slope in the human distal coronary artery segments (0.68 +/- 0.07) was significantly less than unity and BIBN4096BS potently blocked these responses (pK(b) (10 nM): 9.29 +/- 0.34, n = 5). In the same preparation, h-alphaCGRP(8-37) behaved as a weak antagonist of h-alphaCGRP-induced relaxations (pK(b) (3 microM): 6.28 +/- 0.17, n = 4), with also a Schild plot slope smaller than unity. The linear agonists, [ethylamide-Cys(2,7)]-h-alphaCGRP ([Cys(Et)(2,7)]-h-alphaCGRP) and [acetimidomethyl-Cys(2,7)]-h-alphaCGRP ([Cys(Acm)(2,7)]-h-alphaCGRP), had a high potency (pEC(50): 8.21 +/- 0.25 and 7.25 +/- 0.14, respectively), suggesting the presence of CGRP(2) receptors, while the potent blockade by BIBN4096BS (pK(b) (10 nM): 10.13 +/- 0.29 and 9.95 +/- 0.11, respectively) points to the presence of CGRP(1) receptors. Using RT-PCR, mRNAs encoding for the essential components for functional CGRP(1) receptors were demonstrated in both human proximal and distal coronary artery. Further, h-alphaCGRP (100 nM) increased cAMP levels, and this was attenuated by BIBN4096BS (1 microM). The above results demonstrate the presence of CGRP(1) receptors in all coronary artery segments investigated, but the human distal coronary artery segments seem to have an additional population of CGRP receptors not complying with the currently classified CGRP(1) or CGRP(2) receptors.
- Subjects :
- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid pharmacology
Adaptor Proteins, Signal Transducing
Adolescent
Adult
Aged
Animals
Calcitonin Gene-Related Peptide analogs & derivatives
Calcitonin Gene-Related Peptide pharmacology
Calcitonin Receptor-Like Protein
Carrier Proteins genetics
Carrier Proteins metabolism
Child
Child, Preschool
Colforsin pharmacology
Coronary Vessels metabolism
Coronary Vessels physiology
Cyclic AMP metabolism
Dose-Response Relationship, Drug
Endothelium, Vascular physiology
Female
Humans
In Vitro Techniques
Intracellular Signaling Peptides and Proteins genetics
Intracellular Signaling Peptides and Proteins metabolism
Male
Membrane Proteins genetics
Membrane Proteins metabolism
Middle Aged
Piperazines pharmacology
Potassium Chloride pharmacology
Protein Isoforms genetics
Protein Isoforms physiology
Quinazolines pharmacology
Receptor Activity-Modifying Proteins
Receptors, Calcitonin genetics
Receptors, Calcitonin metabolism
Receptors, Calcitonin Gene-Related Peptide genetics
Reverse Transcriptase Polymerase Chain Reaction
Substance P pharmacology
Swine
Time Factors
Transcription Factor Brn-3A genetics
Transcription Factor Brn-3A metabolism
Vasoconstrictor Agents pharmacology
Vasodilation drug effects
Coronary Vessels drug effects
Receptors, Calcitonin Gene-Related Peptide physiology
Subjects
Details
- Language :
- English
- ISSN :
- 0014-2999
- Volume :
- 530
- Issue :
- 1-2
- Database :
- MEDLINE
- Journal :
- European journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 16375887
- Full Text :
- https://doi.org/10.1016/j.ejphar.2005.11.020